Serotonin now: clinical implications of inhibiting its synthesis with para-chlorophenylalanine.
D000328:Adult; D000368:Aged; D000818:Animals; D001519:Behavior / Q000187:drug effects*; D001923:Brain Chemistry; D002396:Catechols / Q000494:pharmacology; D002417:Cattle; D003863:Depression / Q000209:etiology*; D003967:Diarrhea / Q000188:drug therapy; D004285:Dogs; D004792:Enzyme Precursors / Q000627:therapeutic use; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine; D008297:Male; D008303:Malignant Carcinoid Syndrome / Q000188:drug therapy*; D008875:Middle Aged; D010649:Phenylalanine / Q000009:adverse effects / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012701:Serotonin / Q000096:biosynthesis / Q000502:physiology*; D012702:Serotonin Antagonists; D012726:Sexual Behavior, Animal / Q000187:drug effects*; D012895:Sleep, REM / Q000187:drug effects*; D013739:Testosterone / Q000502:physiology; D014364:Tryptophan / Q000037:antagonists & inhibitors / Q000494:pharmacology; D014666:Vasomotor System / Q000187:drug effects
D002396:Catechols; D004792:Enzyme Precursors; D012702:Serotonin Antagonists; D012701:Serotonin; D013739:Testosterone; D010649:Phenylalanine; D006897:Hydroxyindoleacetic Acid; D014364:Tryptophan